Company Overview and News

1
RNAi For Hepatitis B - A False Hope For A Cure?

2018-04-06 seekingalpha
RNAi is a revolutionary and powerful biotech modality that is being utilized for Chronic Hepatitis B.
Upvote Downvote

1
Benitec Biopharma begins phase II clinical study for head and neck cancer treatment

2018-03-05 proactiveinvestors.com.au
Benitec Biopharma Ltd (ASX:BLT) (NASDAQ:BNTC) has commenced a phase II clinical study in Australia with BB-401 as a treatment for patients with head and neck squamous cell carcinoma (HNSCC).
Upvote Downvote

 
Benitec Biopharma's (BNIKF) CEO Greg West on Q2 2018 Results - Earnings Call Transcript

2018-02-27 seekingalpha
Thank you for standing by and welcome to the Benitec Biopharma Quarterly Corporate Update Conference Call.
Upvote Downvote

 
Benitec Biopharma (BTEBY) Presents At 10th Annual Biotech Showcase 2018 - Slideshow

2018-01-09 seekingalpha
The following slide deck was published by Benitec Biopharma Ltd ADR in conjunction with this event.
Upvote Downvote

1
Your Daily Pharma Scoop: Valeant's B+L In India, TXMD's NDA Resubmission, Melinta Makes An Acquisition

2017-11-30 seekingalpha
We discuss Bausch and Lomb’s India sales, and whether that has any bearing on Valeant’s woes.
Upvote Downvote

 
Benitec Biopharma’s shares ride higher after securing new U.S. patent

2017-10-18 proactiveinvestors.com.au
Benitec Biopharma Ltd’s (ASX:BLT) shares closed 20% higher on Wednesday after securing a new patent related to its hepatitis B program in the U.S.
Upvote Downvote

 
Technical Reports on Biotech Equities -- BioDelivery Sciences, BioLine Rx, Benitec Biopharma, and Soligenix

2017-08-01 prnewswire
If you want a Stock Review on BDSI, BLRX, BNTC or SNGX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com has initiated coverage on BioDelivery Sciences International Inc. (NASDAQ: BDSI), BioLine Rx Ltd (NASDAQ: BLRX), Benitec Biopharma Ltd (NASDAQ: BNTC), and Soligenix Inc. (NASDAQ: SNGX). These equities operate in the Biotech space, which consists of companies engaged in the research and development of new drugs, medical devices, and procedures.
Upvote Downvote

1
The Alliance for Regenerative Medicine Announces Presenting Companies at 2017 Cell & Gene Meeting on the Mesa

2017-07-19 marketwired
WASHINGTON, DC--(Marketwired - Jul 19, 2017) - The Alliance for Regenerative Medicine (ARM) today announced the initial slate of companies selected to present at its upcoming Cell & Gene Meeting on the Mesa annual conference, October 4-6, 2017.
Upvote Downvote

 
Benitec Biopharma's (BNIKF) CEO Greg West on Q1 2017 Results - Earnings Call Transcript

2017-05-31 seekingalpha
Thank you for standing by and welcome to the Benitec Biopharma Quarterly Corporate Update Conference Call.
Upvote Downvote

 
How These Biotech Stocks are Faring? -- Cymabay Therapeutics, Benitec Biopharma, Sage Therapeutics, and Catalyst Biosciences

2017-04-26 prnewswire
On Tuesday, April 25, 2017, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Eight out of nine sectors ended Tuesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, Stock-Callers.com assessed the following Biotechnology equities this morning: Cymabay Therapeutics Inc. (NASDAQ: CBAY), Benitec Biopharma Ltd (NASDAQ: BNTC), Sage Therapeutics Inc.
Upvote Downvote

 
Research Reports Initiation on Banking Stocks -- Comerica, Home Bancshares, Bank of Montreal, and Canadian Imperial Bank of Commerce

2017-04-26 prnewswire
On Tuesday, April 25, 2017, US markets saw broad based gains with eight out of nine sectors finishing the trading sessions in green. Major US indices were also bullish at the close of yesterday's session. The NASDAQ Composite ended the day at 6,025.49, up 0.70%; the Dow Jones Industrial Average edged 1.12% higher, to finish at 20,996.12; and the S&P 500 closed at 2,388.61, up 0.61%. This Wednesday morning, Stock-Callers.
Upvote Downvote

 
Appointment of Chairman

2017-04-20 londonstockexchange
Redx Pharma, the research and development company focused on cancer, immunology and infection, announces that it has appointed Mr Iain Ross as Chairman of its Board of Directors and as a Non-Executive Director of the Company, effective from 1st May 2017.
Upvote Downvote

 
Here's Why Benitec Biopharma Stock Soared 79.7% Higher This Morning

2017-04-04 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
BRIEF-Hydropothecary Corp reports Q2 net loss per share $ 0.13

2017-04-04 reuters
LONDON, April 4 Global investment banking fees reached a 10-year high in the first quarter of 2017 with more than half of the $24 billion in total takings coming from North America, Thomson Reuters data showed on Tuesday.
Upvote Downvote

 
BRIEF-Solar Alliance signs letter of intent to acquire U.S. solar assets

2017-04-04 reuters
* Solar Alliance Energy - as per loi, co will acquire seller's team of employees and acquire seller's pipeline of in-process residential solar projects
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

23h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...